Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Insite Vision Inc. -- Ignore unavailable to you. Want to Upgrade?

To: NYBellBoy who wrote (756)	6/21/1998 11:37:00 AM
From: Todd	Read Replies (2) \| Respond to of 1060

I subscribed to Murphy for several years, and I thought he said that Insite vision was a large holding in his Biotech fund. I just ran across this listing of his holding for 1998, insite vision does not look like a big holding any more. or was I incorect in my statement. Possibly ISV was a big holding in his private fund? ---------------- Murphy New World Biotechnology Fund The Biotechnology Fund's objective is long term growth of capital through investing primarily in equity securities of companies we believe can produce products or services that provide or benefit from advances in biotechnology. Top Ten Holdings in the Fund on April 30, 1998 Company (Ticker Symbol) Cephalon (CEPH) Guilford Pharmaceuticals (GLFD) Amgen (AMGN) Xoma (XOMA) Chiron (CHIR) Amylin Pharmaceuticals (AMLN) Trega Biosciences (TRGA) Axys Pharmaceuticals (AXPH) Supergen Inc. (SUPG) Cocensys (COCN)